article thumbnail

Increased Risk of Heart Rhythm Disruption After COVID-19

DAIC

Ioannis Katsoularis, image courtesy of Klas Sjöberg milla1cf Thu, 12/14/2023 - 09:23 December 14, 2023 — Individuals infected with COVID-19 are also at an increased risk of suffering from heart rhythm disturbances, such as atrial fibrillation. We could also see that unvaccinated people were at higher risk than vaccinated people.

COVID-19 111
article thumbnail

Symptoms of viral influenza, COVID-19, norovirus, and RSV can be signs of potential heart complications, warn experts

Medical Xpress - Cardiology

With a recent surge in influenza, COVID-19, norovirus, respiratory syncytial virus (RSV), and other respiratory viruses, it's critical to pay close attention to your heart and symptomsespecially if you have heart disease or the risk factors for it.

COVID-19 111
article thumbnail

Chung-Ang University Study Looks at Cardiovascular Risks in COVID-19 Survivors

DAIC

The cumulative incidence of MACE and all- cause of mortality in COVID-19 and non-COVID-19 pneumonia groups. The results indicate a lower risk of cardiovascular disease in COVID-19 patients. The results indicate a lower risk of cardiovascular disease in COVID-19 patients.

COVID-19 103
article thumbnail

Mendelian randomization supports genetic liability to hospitalization for COVID-19 as a risk factor of pre-eclampsia

Frontiers in Cardiovascular Medicine

Existing observational research presents conflicting evidence regarding the causal effects of coronavirus disease 2019 (COVID-19) on pre-eclampsia risk. Results Critical ill COVID-19 [defined as hospitalization for COVID-19 with either a death outcome or respiratory support, OR (95% CI): 1.17 (1.03–1.33),

article thumbnail

Active Vitiligo Considered a Risk Factor for Vitiligo Progression Following COVID-19 Vaccination

HCPLive

These data indicate the necessity of further research to clarify any associations between COVID-19 infection, the virus’s associated vaccines, and progression of vitiligo.

article thumbnail

Comorbidities Pose Higher Risk of Severe COVID-19 Outcomes Than IMIDs

HCPLive

An IMID diagnosis or use of immunomodulatory medications were not shown to be a significant risk factor of severe COVID-19 outcomes.

article thumbnail

Immune-Mediated Inflammatory Diseases like RA Linked to Severe COVID-19 Outcomes

HCPLive

Age, chronic comorbidities, and COVID-19 vaccination status in patients with IMIDs serve as risk factors for severe COVID-19 outcomes.